Heidi Cuthbert - Author on Grafa
All
bioAffinity revenue hits $6.2M as CyPath lung adoption surges 87%
bioAffinity Technologies (NASDAQ:BIAF) reported fiscal year 2025 results that underscore an aggressive transition from a broad laboratory service model to a specialized, high-growth diagnostic powerhouse focused on early-stage lung cancer detection.
Eupraxia Pharmaceuticals extends runway to 2028 on positive "RESOLVE" data
Eupraxia Pharmaceuticals (NASDAQ:EPRX) has secured a long-term financial runway, shifting focus toward pivotal data readouts for its lead gastrointestinal program following a successful fourth quarter and a transformative February financing.
Enterprise Metals hits high-grade REE at Cuddingwarra North
Enterprise Metals has announced high-grade assay results from its maiden reverse circulation (RC) drilling program at the Cuddingwarra North rare earth element (REE) project in Western Australia.
The 14-hole program targeting the Emily Well prospect saw 13 holes intersect total rare earth oxides (TREO) above 300ppm, with 10 holes exceeding 400ppm.










